Alexander Bick
-
New view of mutations informs disease risk, treatment response
A transcontinental research effort led by scientists from Vanderbilt University Medical Center and the University of Michigan has upended some long-standing assumptions about mutations — how often they occur, what causes them and what they do. Read MoreMay 18, 2023
-
Research identifies new target that may prevent blood cancer
An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer. Read MoreApr 12, 2023
-
Researchers clarify role of blood cell mutations in disease
Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells. Read MoreFeb 2, 2023
-
Three Vanderbilt biomedical researchers named 2022 Pew Scholars
Mariana Byndloss, assistant professor of pathology, microbiology and immunology, and William Wan, assistant professor of biochemistry, have been named 2022 Pew Scholars in the Biomedical Sciences. The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust have selected Alexander Bick, assistant professor of genetic medicine, to join the 2022 class of Pew-Stewart Scholars for Cancer Research. Read MoreJun 14, 2022
-
Gene variants increase risk of kidney failure in Black veterans with COVID-19: study
Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19. Read MoreFeb 10, 2022